WPC m_Ic xZIyJyes݆(1'NDDRLu2Ki#S49cRDZHA'|DMs>`x[t>T#Tkkg]zI }RfcZ%ΩMSG{>שfB/i; ?݌bL$?Gn )[b[6 tW;bkM8Eʻ:K05<_Dm{fhfv%:B'm슀zv9.TȿSxֿS$/Mf`WKOn4y$[2xA~ib4=Ė1:mLZǠgM_)\1 *x `XXAgktG`e$i7Q<^oo&'? `i|dߌ"U=:n %c 0O;  0O' 1Yv  04 # (N 1u 72{^ w4 m 72 B9U2AEsU,u 0c 1s 72wU8@ 1u 72^<6X9`("Courier 10cpi<6X9`("Courier 10cpiXx6X@8QX@X' 1995 serology study questions 2sq  0 .     O)   _ 6XXjr6?' XxdE W(#? X X X0?g_ #6jrr# 6MLAB_Ԁ2361#XX S# XXClinicalII#6 L# jr6#X Xjr#jr XX$$($%  1  #6jr##XXX6:#('2O$  U!     O'   _XX XXX #XXX XXE#XXXXXSerologyReviewQuestions#XXXXX# X XXXX(#(#K(# X A) AxdEX A#XXX XX#('2O$  U!   4c35;ACIKMO11.A.1.#|x ( U$  HP Officejet J6400 series0!3#37=CIQYag1.a.i.(1)(a)(i)1)a)i)i:  Ad:rtyBarqo U  d .D4A`Helvetica,cAZArial (;3$2#  0  .3  0  337=CIOW_eI.A.1.a.(1)(a)i)a)1)&d9 Z(Times New Roman 7#137=CIQYag1.a.i.(1)(a)(i)1)a) i)  U!   _XXXXXXXX@# StudyQuestions   Name________________________Date________________________   Directions:0   Thesestudyquestionsareprovidedforyouruseinpreparationfortheserologyrotationfinalexam. IL Answersarewithinreadingassignments,lecturepresentations,orfromproductinserts.Thesewill   NOTbegradedandaretobeusedforyoutoevaluateyourownlevelofknowledge. %% *X` X* (c43 (#34 "3"  32#  1  .3  0 P   Brieflydefinethefollowing:3+݌k n P%P% Ќ   (c43} (#174  P 2 #1  a  .3  0  activeimmunity %%  P 2 #1  b  .3  0  passiveimmunity %%  P 2 #1  c  .3  0  antibodytitration%% 2 #1  2  .3  0 P Contrastnaturallyproducedimmunityfromartificiallyproducedimmunity.#&P%P% 2 #1  3  .3  0 P Contrastprimaryandsecondary(anamnestic)immuneresponsesastolengthoflatentphase,speedof  antibodyproduction,andgeneralclassofantibodyproduced.P%P% 2 #1  4  .3  0 P Identifythetwotypesoflightchainsfoundinhumanimmunoglobulin?%!+P%P% 2 #1  5  .3  0 P Whichimmunoglobulinclassisfoundinthehighestconcentrationinnormalhumanserum?)%0P%P%  P 2 #1  a  .3  0  _IgM_*&1%%  P 2 #1  b  .3  0  _IgG_s+v'2%%  P 2 #1  c  .3  0  _IgA_;,>(3%%  P 2 #1  d  .3  0  _IgD_-)4%%  -)5 Ї2 #1  6  .3  0 P Whatisthefirstantibodyproducedinhumoralimmunity?Whichantibodyclassisproducedinanamnestic  response?P%P% 2 #1  7  .3  0 P Identifythetermusedtodescribeanantibodywhichbindscomplementandcausesredcelllysis. P%P%  P 2 #1  8  .3  0 P Listfourfactorswhichinfluenceantigenantibodyreactions.u xP%P%  P   2 #1  9  .3  0 P Compareandcontrast_hapten_Ԁwithantigen.%( P%P% 2 #1  10  .3  0 P Whatisthenumberedorderinwhichthecomplementcomponentsareactivatedintheclassicalpathway?  alternatepathway?P%P% 2 #1  11  .3  0 P Compareagglutinationwithhemagglutination.P%P% 2 #1  12  .3  0 P Brieflydescribethefourreactioncombinationsthatoccuringels.58P%P% 2 #1  13  .3  0 P Describeradialimmunodiffusion(RID).Includewhatismixedintheagar,andwhatisbeingquantitatedand $ ) how.$ *P%P% 2 #1  14  .3  0 P CompareandcontrastRIDandOuchterlonygeldiffusion?})%0P%P%  -.0*6 Ї2 #1  15  .3  0 P Whatthreeprincipletypeofreactionsmaybeobservedin_Ouchterlony_Ԁgeldiffusion?P%P% 2 #1  16  .3  0 P Comparetheterms competitiveand noncompetitiveastheyrelateto_immunoassays_.P%P% 2 #1  17  .3  0 P #XXXXXS#XXXXXComparetheterms homogeneousand heterogeneousastheapplyto_immunoassays_.#XXXXX#XXXXX] ` P%P% 2 #1  18  .3  0 P #XXXXX#XXXXXUsea separatesheetofpaper toBRIEFLYdescribethefollowingmethods: P%P%  P 2 #1  a  .3  _Turbidimetry_   P 2 #1  b  .3  _Nephelometry_   P 2 #1  c  .3  Electrophoresis gj  P 2 #1  d  .3  Immunoelectrophoresis /2  P 2 #1  e  .3  _Immunofixation_Ԁelectrophoresis   P 2 #1  f  .3  _Radioimmunoassay_   P 2 #1  g  .3  _Immunoradiometric_Ԁassay(IRMA)   P 2 #1  h  .3  Enzyme_Immunoassay_Ԁ(_ELISA_) OR  P 2 #1  i  .3  Fluorescent_Immunoassay_Ԁ   P 2 #1  j  .3  FluorescentPolarization   P 2 #1  k  .3  Chemiluminescent_Immunoassay_   P 2 #1  l  .3  NucleicAcidProbe or  P 2 #1  m  .3  HybridizationTechniques 7:  P   2 #1  i  .3  Dotblot    P   2 #1   ii  .3  Sandwichhybridization !  P   2 #1   iii  .3  Southernblot "  P   2 #1   iv  .3  Northernblot WZ#  P   2 #1   v  .3  Solutionhybridization  "$  P   2 #1   vi  .3  Insituhybridization  %  P   2 #1   vii  .3  DNA_Microarray_ !&  P 2 #1   n  .3  #XXXXX#XXXXXTargetamplification w"z'  P   2 #1  i  .3  ԀPolymeraseChainReaction(PCR) ?#B(  P   2 #1  ii  .3  _Ligase_ԀChainreaction $ ) #XXXXX[$#XXXXX2 #1  19  .3  0 P #XXXXX%#XXXXXWhatisthepathogenicorganismresponsibleforhumansyphilis?''*#-P%P% 2 #1  20  .3  0 P #XXXXX&#XXXXXHowishumansyphilistransmitted?)%0P%P%  /.2*6 Ї2 #1  21  .3  0 P Describethesymptomsandresultsofserologictestsforeachstageofsyphilis.P%P% 0 P PrimaryP%P% 0 P 0P%P%1stweek0p%%򀀀UXp%p% 0 P 0P%P%2ndweek0@(#(# %% 0 P SecondaryP%P% 0 P LateLatent= @P%P% 0 P Tertiary  P%P% 2 #1  22  .3  0 P Identify2syphilisteststhatareclassifiedas reagintests.Describethenextstepifapositivereagintestis   obtainedonapatient? P%P% 2 #1  23  .3  0 P Definebiologicfalsepositiveasitrelatestosyphilistesting.P%P% 2 #1  24  .3  0 P Listatleastfour(4)causesoffalsenegativesintheVDRLand_RPR_Ԁtest.P%P%  P 2 #1  25  .3  0 P CompareandcontrasttheVDRLandRPRtestsastothesubstancedetected,antigenused,timeandspeed ! ofrotation,andhowthetestisread."P%P%  P Substancedetected  $  P antigenmakeup !&  P time/speedofrotationoftestcard/slide =#@(  P methodusedtoreadtestresults $ * 2 #1  26  .3  0 P TheantigencarrierintheRPRtestis%'(#-P%P%  P 2 #1  a  .3  0  redbloodcells'#.%%  P 2 #1  b  .3  0  latexparticles($/%%  P 2 #1  c  .3  0  bacterialsuspension})%0%%  P 2 #1  d  .3  0  charcoalE*H&1%%  -.0*6 Ї2 #1  27  .3  0 P StatetheexpectedresultsforthefollowingRPRQualityControlchecks.P%P%  P 2 #1  a  .3  0  needledeliveryUX%%  P 2 #1  b  .3  0  rotatorRPM%%  P 2 #1  c  .3  0  roomtemperatureu x%%  P 2 #1  d  .3  0  controlserums  %%  P 2 #1  28  .3  0 P ListfourspecificTreponmenaltestswhichmaybeperformedwhenapositivereagintestisobtained.  P%P% #XXXXX{'#XXXXX#XXXXX5#XXXXX2 #1  29  .3  0 P #XXXXX6#XXXXXWhatarethechallengesfortestinginfantsforsyphilis?P%P% | eh 2 #1  30  .3  0 P #XXXXX6#XXXXXWhattypeofsyphilistestisperformedonCSF?P%P% 2 #1  31  .3  0 P WhatisCreactiveprotein?MPP%P% 2 #1  32  .3  0 P WhatistheprincipleoftheCRPlatexagglutinationtest?mpP%P% 2 #1  33  .3  0 P Whataretwo(2)advantagesthattheCRPtesthasovertheerythrocytesedimentationrate(ESR)test? %P%P% 2 #1!  34  .3  0 P Anelevatedtiterofcoldagglutininsisfoundinwhatpercentageofpatientswithprimaryatypicalpneumonia?%!+P%P%  P 2 #1"  a  .3  0  100%]&`",%%  P 2 #1"  b  .3  0  90%%'(#-%%  P 2 #1"  c  .3  0  55%'#.%%  P 2 #1"  d  .3  0  20%($/%% 2 #1"  35  .3  0 P Identifythecausativeagentofprimaryatypicalpneumonia.E*H&1P%P%  -.0*6 Ї2 #1#  36  .3  0 P Statetheprincipleofthecoldagglutinintestincludingthespecificityoftheantibodyinvolved.P%P% 2 #1$  37  .3  0 P #XXXXX7#XXXXXInthecoldagglutinintiterwhatwouldindicateaclinicallysignificantriseintiter?P%P% 2 #1%  38  .3  0 P #XXXXX>#XXXXXInthecoldagglutinintiterstatethecontentsoftube12andtheexpectedresult.Whatmustbedoneifthe    expectedresultisnotobtained?  P%P% 2 #1&  39  .3  0 P Whatchronicinflammatorydiseaseaffectsprimarilythejointsandperiarticulartissues?} P%P% 2 #1'  40  .3  0 P Whatisrheumatoidfactor?Whatisitsspecificity?P%P% 2 #1(  41  .3  0 P Statetheprincipleofthelatexagglutinationtestfortrheumatoidarthritis?-0P%P% 2 #1)  42  .3  0 P #XXXXX@#XXXXXStatetheorganismresponsiblefortheconditionknownas Strepthroat(genusandspecies)?P%P% 2 #1*  43  .3  0 P #XXXXXC#XXXXXListtwosequellawhichmayoccurifastrepthroatisleftuntreated.mpP%P% 2 #1+  44  .3  0 P #XXXXXD#XXXXXListthetermusedfortheskininfectioncausedbystrep."P%P% 2 #1,  45  .3  0 P Listfive_exoantigens_ԀwhichareproducedbyStrep.u"x'P%P%  P      p 2 #1-  46  .3  0 P ListfiveantibodiesproducedinresponsetoaStrepinfectionwhicharemostusefulforlaboratorytesting.($/P%P%  -.0*6 Ї2 #1.  47  .3  0 P #XXXXXE#XXXXXStatetheprincipleofthe_Streptozyme_Ԁtest(getfromlaboratoryprocedure).P%P% 2 #1/  48  .3  0 P Statethecausativeagentofinfectiousmononucleosis?= @P%P% #XXXXXnH#XXXXX2 #10  49  .3  0 P #XXXXXI#XXXXXBrieflylistthesymptomsofaninfectiousmononucleosisinfection.] ` P%P% 2 #11  50  .3  0 P #XXXXXvJ#XXXXXDescribethehematologicalpictureseenonaperipheralsmearininfectiousmononucleosisincludingwhich  whitecelltypewillbemostpredominant.P%P% 2 #12  51  .3  0 P #XXXXXtK#XXXXXDefinethefollowingterms:_heterophile_Ԁantigen,_heterophile_Ԁantibody,_Forssman_Ԁantigenand_Forssman_  antibody.P%P% ______________2 #13  52  .3  0 P WhatistheprincipleofthePaul_Bunnell_Ԁscreeningtestforinfectiousmononucleosis?Whatisthe u"x' significanceofapositivetest?=#@(P%P% __2 #14  53  .3  0 P #XXXXXL#XXXXXState#XXXXXP#XXXXXtheprincipleofthemononucleosisslidetest.})%0P%P% 2 #15  54  .3  0 P #XXXXXP#XXXXXDescribethetransmissionofcytomegalovirus.,(4P%P%  -.0*6 Ї2 #16  55  .3  0 P #XXXXXQ#XXXXXDescribetheclinicalsymptomsofcytomegalovirusinfectionincludingpopulationsmostatrisk.P%P% 2 #17  56  .3  0 P #XXXXXR#XXXXXBrieflylistlaboratorymethodsusedforthediagnosisofcytomegalovirusinfection.P%P% #XXXXXS#XXXXX2 #18  57  .3  0 P State#XXXXXT#XXXXXthesubstancewhichisdetectedinapositivepregnancytest.  P%P% 2 #19  58  .3  0 P #XXXXX.U#XXXXXHowlongmayaurinesamplebeusedforapregnancytestifstoredatroomtemperature?Ifstoredinthe %(  refrigerator? P%P% 2 #1:  59  .3  0 P State#XXXXXV#XXXXXԀtheprincipleofthefollowingtypesofpregnancytests: P%P%  P 2 #1;  a  .3  0  latexagglutination%%  P 2 #1;  b  .3  0  monoclonalantibody(ELISA)testMP%% 2 #1;  60  .3  0 P Listatleastfour(4)diseasesorconditionsOTHERthanpregnancywhichmayresultinapositivepregnancy " test.UX#P%P% 2 #1<  61  .3  0 P StatethecausativeagentofLymesDisease.$ )P%P% 2 #1=  62  .3  0 P #XXXXX_W#XXXXXNamethevectorresponsiblefortransmissionofLymesdisease.]&`",P%P% 2 #1>  63  .3  0 P #XXXXX [#XXXXXHowlongmustthevectorremainattachedfortransmissionoftheagentofLymesdiseasetooccur?($/P%P%  -.0*6 2 #1?  64  .3  0 P ListanddescribethreestagesofLymesDisease.P%P% 2 #1@  65  .3  0 P ListthethreetypesoftestscommonlyperformedteststoassistinthediagnosisofLymesdisease.Which  oneismostsensitive?u xP%P% 2 #1A  66  .3  0 P State#XXXXX\#XXXXXtheclinicalsignificanceofhaptoglobin?] ` P%P% #XXXXX^#XXXXX@*2 #1B  67  .3  0 P State#XXXXXr_#XXXXXthenormalvaluesforhaptoglobin?P%P% 2 #1C  68  .3  0 P CompareandcontrastinfectionsduetoHSV1andHSV2.P%P%  P      p 2 #1D  69  .3  0 P #XXXXX`#XXXXXBrieflyliststhelaboratorytestmethodsusedtodiagnoseHSV1andHSV2.58P%P% 2 #1E  70  .3  0 P #XXXXXa#XXXXXListtheorganismsresponsibleforandgiveabriefdescriptionofchickenpoxandshingles. $P%P% 2 #1F  71  .3  0 P #XXXXXb#XXXXXListthelaboratorytestsutilizedtodetectinfectionsduetochickenpoxandshingles.$ )P%P% 2 #1G  72  .3  0 P #XXXXXc#XXXXXStatethediseasecausedbytheRubellavirusandlistthesymptomsofthedisease.'#.P%P% @*2 #1H  73  .3  0 P #XXXXXd#XXXXXDescribetheconditionknownas congenitalrubella. +'2P%P%  -.0*6 Ї2 #1I  74  .3  0 P #XXXXXe#XXXXXList3laboratorymethodologiesutilizedtodetectrubellaantibodies.P%P% 2 #1J  75  .3  0 P #XXXXXf#XXXXXStatethediseasecausedbytherubeolavirusandlistthesymptomsofthedisease.P%P% 2 #1K  76  .3  0 P #XXXXXg#XXXXXIntestingforrubeolawhatantibodyclassismostfrequentlylookedfor?Why?  P%P% 2 #1L  77  .3  0 P #XXXXXh#XXXXXListthreemethodologiesutilizedtodetectrubeolaantibodies.} P%P% 2 #1M  78  .3  0 P #XXXXXi#XXXXXListthesignsandsymptomsofmumps.ehP%P% 2 #1N  79  .3  0 P #XXXXXj#XXXXXStatethesignificanceof_IgM_Ԁand_IgG_Ԁantibody_titers_Ԁduringamumpsinfection.P%P% 2 #1O  80  .3  0 P Statetherouteoftransmissionforthefivetypesofhepatitisviruses. P%P% %%P%2 #1P  81  .3  0 P WhichhepatitisvirusrequiresaninfectionwithHepatitisBinorderforinfectiontooccur?=#@(P%P% 2 #1Q  82  .3  0 P StatethesignificanceofpresenceofIgMversusIgGclasshepatitisantibodiesindeterminingthestatusof %!+ theinfectionofsomeonewithhepatitis.]&`",P%P%  P  -.0*6 2 #1R  83  .3  #XXXXXk#XXXXX0 P ForhepatitisB,listthreemarkersusedfordiagnosisandthesignificanceofeachone.P%P% @*2 #1S  84  .3  0 P #XXXXXo#XXXXXStatetheetiologicagentofAcquiredImmunodeficiencySyndrome(AIDS).] ` P%P% 2 #1T  85  .3  0 P #XXXXX+q#XXXXXListthethreemainstructuralgenesofHIV.P%P% 2 #1U  86  .3  0 P #XXXXX(r#XXXXXState4methodsoftransmissionofHIV.P%P% 2 #1V  87  .3  0 P #XXXXXs#XXXXXListanddescribethestagesofanHIVinfectionINCLUDINGpertinentlaboratoryresultsofeach,_ie_,antibody  presence,CD4count,etc.#XXXXXs#